• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结合配体和基于结构的虚拟筛选方法以鉴定新型乙酰胆碱酯酶抑制剂。

Combined ligand and structure-based virtual screening approaches for identification of novel AChE inhibitors.

作者信息

Şahİn Kader, DurdaĞi Serdar

机构信息

Computational Biology and Molecular Simulations Laboratory, Department of Biophysics, School of Medicine, Bahçeşehir University, Istanbul Turkey.

出版信息

Turk J Chem. 2020 Jun 1;44(3):574-588. doi: 10.3906/kim-1911-57. eCollection 2020.

DOI:10.3906/kim-1911-57
PMID:33488178
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7671205/
Abstract

The excessive activity of acetylcholinesterase enzyme (AChE) causes different neuronal problems, especially dementia and neuronal cell deaths. Food and Drug Administration (FDA) approved drugs donepezil, rivastigmine, tacrine and galantamine are AChE inhibitors and in the treatment of Alzheimer's disease (AD) these drugs are currently prescribed. However, these inhibitors have various adverse side effects. Therefore, there is a great need for the novel selective AChE inhibitors with fewer adverse side effects for the effective treatment. In this study, combined ligand-based and structure-based virtual screening approaches were used to identify new hit compounds from small molecules library of National Cancer Institute (NCI) containing approximately 265,000 small molecules. In the present study, we developed a computational pipeline method to predict the binding affinities of the studied compounds at the specific target sites. For this purpose, a text mining study was carried out initially and compounds containing the keyword "indol" were considered. The therapeutic activity values against AD were screened using the binary quantitative structure activity relationship (QSAR) models. We then performed docking, molecular dynamics (MD) simulations and free energy analysis to clarify the interactions between selected ligands and enzyme. Thus, in this study we identified new promising hit compounds from a large database that may be used to inhibit the enzyme activity of AChE.

摘要

乙酰胆碱酯酶(AChE)的过度活性会引发不同的神经元问题,尤其是痴呆和神经元细胞死亡。美国食品药品监督管理局(FDA)批准的药物多奈哌齐、卡巴拉汀、他克林和加兰他敏是AChE抑制剂,目前在治疗阿尔茨海默病(AD)时会使用这些药物。然而,这些抑制剂有各种不良副作用。因此,迫切需要新型选择性AChE抑制剂,其副作用更少,以便进行有效治疗。在本研究中,结合基于配体和基于结构的虚拟筛选方法,从美国国立癌症研究所(NCI)包含约265,000个小分子的小分子库中鉴定新的命中化合物。在本研究中,我们开发了一种计算管道方法来预测所研究化合物在特定靶位点的结合亲和力。为此,首先进行了一项文本挖掘研究,并考虑了包含关键词“吲哚”的化合物。使用二元定量构效关系(QSAR)模型筛选针对AD的治疗活性值。然后我们进行对接、分子动力学(MD)模拟和自由能分析,以阐明所选配体与酶之间的相互作用。因此,在本研究中,我们从一个大型数据库中鉴定出了新的有前景的命中化合物,这些化合物可用于抑制AChE的酶活性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd2c/7671205/eb261ecfd9c2/turkjchem-44-574-fig007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd2c/7671205/d04eca24ab43/turkjchem-44-574-fig001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd2c/7671205/7125e1d91863/turkjchem-44-574-fig002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd2c/7671205/1d771cf42103/turkjchem-44-574-fig003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd2c/7671205/d33091169750/turkjchem-44-574-fig004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd2c/7671205/6304414b0333/turkjchem-44-574-fig005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd2c/7671205/2effab4a50e4/turkjchem-44-574-fig006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd2c/7671205/eb261ecfd9c2/turkjchem-44-574-fig007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd2c/7671205/d04eca24ab43/turkjchem-44-574-fig001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd2c/7671205/7125e1d91863/turkjchem-44-574-fig002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd2c/7671205/1d771cf42103/turkjchem-44-574-fig003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd2c/7671205/d33091169750/turkjchem-44-574-fig004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd2c/7671205/6304414b0333/turkjchem-44-574-fig005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd2c/7671205/2effab4a50e4/turkjchem-44-574-fig006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd2c/7671205/eb261ecfd9c2/turkjchem-44-574-fig007.jpg

相似文献

1
Combined ligand and structure-based virtual screening approaches for identification of novel AChE inhibitors.结合配体和基于结构的虚拟筛选方法以鉴定新型乙酰胆碱酯酶抑制剂。
Turk J Chem. 2020 Jun 1;44(3):574-588. doi: 10.3906/kim-1911-57. eCollection 2020.
2
Novel AChE and BChE inhibitors using combined virtual screening, text mining and in vitro binding assays.使用组合虚拟筛选、文本挖掘和体外结合测定法筛选新型 AChE 和 BChE 抑制剂。
J Biomol Struct Dyn. 2020 Jul;38(11):3342-3358. doi: 10.1080/07391102.2019.1660218. Epub 2019 Oct 6.
3
Discovery of Novel Acetylcholinesterase Inhibitors as Potential Candidates for the Treatment of Alzheimer's Disease.发现新型乙酰胆碱酯酶抑制剂作为治疗阿尔茨海默病的潜在候选药物。
Int J Mol Sci. 2019 Feb 25;20(4):1000. doi: 10.3390/ijms20041000.
4
Integrating Ligand and Target-Driven Based Virtual Screening Approaches With Human Cell Line Models and Time-Resolved Fluorescence Resonance Energy Transfer Assay to Identify Novel Hit Compounds Against BCL-2.整合基于配体和靶点驱动的虚拟筛选方法与人类细胞系模型及时间分辨荧光共振能量转移测定法,以鉴定针对BCL-2的新型活性化合物。
Front Chem. 2020 Apr 9;8:167. doi: 10.3389/fchem.2020.00167. eCollection 2020.
5
Combined 3D-QSAR, molecular docking, and molecular dynamics study of tacrine derivatives as potential acetylcholinesterase (AChE) inhibitors of Alzheimer's disease.他克林衍生物作为阿尔茨海默病潜在乙酰胆碱酯酶(AChE)抑制剂的联合3D-QSAR、分子对接和分子动力学研究
J Mol Model. 2015 Oct;21(10):277. doi: 10.1007/s00894-015-2797-8. Epub 2015 Oct 5.
6
Novel tumor necrosis factor-α (TNF-α) inhibitors from small molecule library screening for their therapeutic activity profiles against rheumatoid arthritis using target-driven approaches and binary QSAR models.基于靶向驱动方法和二元 QSAR 模型,从小分子文库中筛选新型肿瘤坏死因子-α(TNF-α)抑制剂,以评估其治疗类风湿关节炎的活性谱。
J Biomol Struct Dyn. 2019 Jun;37(9):2464-2476. doi: 10.1080/07391102.2018.1491423. Epub 2018 Dec 23.
7
Identification of coumarin derivatives targeting acetylcholinesterase for Alzheimer's disease by field-based 3D-QSAR, pharmacophore model-based virtual screening, molecular docking, MM/GBSA, ADME and MD Simulation study.基于场的3D-QSAR、基于药效团模型的虚拟筛选、分子对接、MM/GBSA、ADME和分子动力学模拟研究鉴定用于阿尔茨海默病的靶向乙酰胆碱酯酶的香豆素衍生物
Curr Res Struct Biol. 2024 Jan 7;7:100124. doi: 10.1016/j.crstbi.2024.100124. eCollection 2024.
8
Investigation of Novel Compounds as Inhibitors of Acetylcholinesterase Enzyme for the Treatment of Alzheimer's Diseases.新型化合物作为乙酰胆碱酯酶抑制剂用于治疗阿尔茨海默病的研究
Int J Alzheimers Dis. 2024 Feb 8;2024:2988685. doi: 10.1155/2024/2988685. eCollection 2024.
9
In silico identification of AChE and PARP-1 dual-targeted inhibitors of Alzheimer's disease.阿尔茨海默病乙酰胆碱酯酶和聚(ADP-核糖)聚合酶-1双靶点抑制剂的计算机模拟鉴定
J Mol Model. 2018 Jun 5;24(7):151. doi: 10.1007/s00894-018-3696-6.
10
identification of angiotensin-1 converting enzyme inhibitors using text mining and virtual screening.使用文本挖掘和虚拟筛选鉴定血管紧张素转化酶抑制剂。
J Biomol Struct Dyn. 2022 Feb;40(3):1152-1162. doi: 10.1080/07391102.2020.1827038. Epub 2020 Oct 5.

引用本文的文献

1
Structural Bioinformatics Applied to Acetylcholinesterase Enzyme Inhibition.结构生物信息学在乙酰胆碱酯酶抑制中的应用
Int J Mol Sci. 2025 Apr 17;26(8):3781. doi: 10.3390/ijms26083781.
2
Identification of novel inhibitors of S-adenosyl-L-homocysteine hydrolase via structure-based virtual screening and molecular dynamics simulations.通过基于结构的虚拟筛选和分子动力学模拟鉴定S-腺苷-L-高半胱氨酸水解酶的新型抑制剂
J Mol Model. 2022 Sep 30;28(10):336. doi: 10.1007/s00894-022-05298-2.
3
Comparison of clinically approved molecules on SARS-CoV-2 drug target proteins: a molecular docking study.

本文引用的文献

1
Application of molecular framework-based data-mining method in the search for beta-secretase 1 inhibitors through drug repurposing.基于分子框架的数据挖掘方法在药物再利用中寻找β-分泌酶 1 抑制剂的应用。
J Biomol Struct Dyn. 2019 Sep;37(14):3674-3685. doi: 10.1080/07391102.2018.1526115. Epub 2018 Nov 13.
2
Secretase inhibitors for the treatment of Alzheimer's disease: Long road ahead.β-分泌酶抑制剂治疗阿尔茨海默病:前路漫漫。
Eur J Med Chem. 2018 Mar 25;148:436-452. doi: 10.1016/j.ejmech.2018.02.035. Epub 2018 Feb 15.
3
New semicarbazones as gorge-spanning ligands of acetylcholinesterase and potential new drugs against Alzheimer's disease: Synthesis, molecular modeling, NMR, and biological evaluation.
SARS-CoV-2药物靶蛋白上临床批准分子的比较:一项分子对接研究。
Turk J Chem. 2021 Feb 17;45(1):35-41. doi: 10.3906/kim-2008-35. eCollection 2021.
新型脒基硫脲类化合物作为乙酰胆碱酯酶的峡谷贯穿配体和潜在的阿尔茨海默病新药:合成、分子模拟、NMR 和生物学评价。
J Biomol Struct Dyn. 2018 Nov;36(15):4099-4113. doi: 10.1080/07391102.2017.1407676. Epub 2017 Dec 7.
4
Probing the interaction of silver nanoparticles with tau protein and neuroblastoma cell line as nervous system models.探究银纳米粒子与tau 蛋白及神经母细胞瘤细胞系的相互作用,作为神经系统模型。
J Biomol Struct Dyn. 2018 Nov;36(15):4057-4071. doi: 10.1080/07391102.2017.1407673. Epub 2017 Dec 21.
5
Protein structure-based drug design: from docking to molecular dynamics.基于蛋白质结构的药物设计:从对接至分子动力学。
Curr Opin Struct Biol. 2018 Feb;48:93-102. doi: 10.1016/j.sbi.2017.10.010. Epub 2017 Nov 14.
6
New approaches for computing ligand-receptor binding kinetics.计算配体-受体结合动力学的新方法。
Curr Opin Struct Biol. 2018 Apr;49:1-10. doi: 10.1016/j.sbi.2017.10.001. Epub 2017 Nov 11.
7
Identification of new BACE1 inhibitors using Pharmacophore and Molecular dynamics simulations approach.使用药效团和分子动力学模拟方法鉴定新型β-分泌酶1(BACE1)抑制剂
J Mol Graph Model. 2017 Sep;76:56-69. doi: 10.1016/j.jmgm.2017.06.001. Epub 2017 Jun 8.
8
Virtual Screening, pharmacophore development and structure based similarity search to identify inhibitors against IdeR, a transcription factor of Mycobacterium tuberculosis.虚拟筛选、药效团开发和基于结构的相似性搜索,以鉴定结核分枝杆菌转录因子 IdeR 的抑制剂。
Sci Rep. 2017 Jul 5;7(1):4653. doi: 10.1038/s41598-017-04748-9.
9
N-(4-Hydroxyphenyl)-3,4,5-trimethoxybenzamide derivatives as potential memory enhancers: synthesis, biological evaluation and molecular simulation studies.N-(4-羟基苯基)-3,4,5-三甲氧基苯甲酰胺衍生物作为潜在的记忆增强剂:合成、生物评价和分子模拟研究。
J Biomol Struct Dyn. 2018 May;36(7):1867-1877. doi: 10.1080/07391102.2017.1336943. Epub 2017 Jun 15.
10
Molecular insights into the inhibitory mechanism of rifamycin SV against β-microglobulin aggregation: A molecular dynamics simulation study.利福霉素SV对β-微球蛋白聚集抑制机制的分子见解:一项分子动力学模拟研究
Int J Biol Macromol. 2017 Sep;102:1025-1034. doi: 10.1016/j.ijbiomac.2017.04.086. Epub 2017 Apr 25.